Načítá se...
Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibition
Despite recent advances in the treatment of chronic lymphocytic leukemia (CLL) with chemoimmunotherapy, many CLL patients are older or frail and cannot tolerate aggressive chemotherapy. Even those who can inevitably develop resistance due to factors such as deletion of pro-apoptotic factors like TP5...
Uloženo v:
| Vydáno v: | Leuk Lymphoma |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4557771/ https://ncbi.nlm.nih.gov/pubmed/23614795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.796051 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|